Nidan Laboratories & Healthcare Ltd (NIDAN) is currently trading at 16.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Nidan Laboratories & Healthcare Limited primarily operates diagnostic centers that offer a comprehensive range of services, including radiology, neurology, cardiology, dental, and pathology. From its founding as a proprietary firm in 1994, Nidan has expanded to 30 diagnostic and collection centers across Mumbai and Pune, integrating advanced diagnostics services under one roof. The company provides services to over one million patients annually, supported by a team of 94 laboratory doctors and 256 technical staff. Nidan places a strong emphasis on customer convenience, offering services such as home specimen collection and digital access to test results, enhancing consumer satisfaction. In 2021, Nidan raised Rs. 50 Crore through an initial public offering, marking a significant milestone in its growth trajectory.

Over the past 52 weeks, Nidan Laboratories & Healthcare Ltd has traded between a low of ₹15.00 and a high of ₹24.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Nidan Laboratories & Healthcare Ltd has a market capitalization of approximately 21.68. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Nidan Laboratories & Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.62 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 21.68 Cr, Nidan Laboratories & Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Nidan Laboratories & Healthcare Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Nidan Laboratories & Healthcare Ltd is 11.62. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.